Hematology

Biography

Shimon Slavin, M.D., is an Israeli professor of medicine. Slavin begin the use of immunotherapy mediated by allogeneic donor lymphocytes and innovative methods for stem cell transplantation for the cure of hematological malignancies and solid tumors, and using hematopoietic stem cells for induction of transplantation tolerance to bone marrow and donor allografts. More recently, he's been working on the use of multi-potent mesenchymal stem cells (MSCs) in regenerative medicine for the treatment of neurological, systemic and orthopedic disorders. He is currently serving as the medical and scientific director of Biotherapy International Center for Innovative Cancer Immunotherapy & Cellular Medicine in Tel Aviv, Israel and as the medical director at Superinfection, a biotechnology company in Budapest, Hungary. Slavin graduated from the School of Medicine at the Hebrew University of Jerusalem and got his degree in 1967. He served as the doctor of the Frogman Unit in the Israeli Navy until 1970. He was trained at the Department of Internal Medicine of the Hebrew University of Jerusalem between 1970 and 1975. In 1975-1978 Shimon Slavin trained in clinical immunology/rheumatology at the Division of Immunology, Stanford University School of Medicine and later on in 1978 trained in clinical bone marrow transplantation under the late Prof. E.D. Thomas at the Fred Hutchinson Cancer Research Center.

Research Interest

Hematology/oncology, Cancer immunotherapy, Regenerative Medicine, Stem cell transplantation, Stem cell treatment Leukemia, Lymphoma, Hodgkin lymphoma, Non-Hodgkin, lymphoma Myeloma Multiple sclerosis, Blood Cancer